Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

NCT01534715

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Ohio State University Columbus, Ohio, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Completed

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

NCT00060424

Conditions
B-Cell Prolymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
Locations
  • Veterans Administration Center-Seattle Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Torino Torino, Italy
View Trial Details
Completed

A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response

NCT00565981

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • A.ö. Landeskrankenhaus Fürstenfeld Fürstenfeld, Austria
  • Universitätsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria
  • A.ö. Landeskrankenhaus Leoben Leoben, Austria
View Trial Details
Completed

Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL

NCT01722487

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Site Reference ID/Investigator #047 Duarte, California, United States
  • Site Reference ID/Investigator #408 La Jolla, California, United States
  • Site Reference ID/Investigator #720 Santa Rosa, California, United States
  • Site Reference ID/Investigator #038 Stanford, California, United States
View all 108 locations
View Trial Details

Related conditions